Literature DB >> 6703939

Computed tomographic patterns of muscles in neuromuscular diseases.

R J Hawley, D Schellinger, D S O'Doherty.   

Abstract

Computed tomographic (CT) scans of muscle in 35 patients with neuromuscular diseases showed distinct patterns in nerve and muscle diseases. Neural diseases first showed as muscle atrophy, with decreased density in the muscles occurring later in the course of disease. Primary muscle diseases showed early decreased density in the muscles, with atrophy occurring later. The CT scan allows objective assessment of muscle mass and may be used to help select muscles for biopsy.

Entities:  

Mesh:

Year:  1984        PMID: 6703939     DOI: 10.1001/archneur.1984.04050160045014

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  13 in total

1.  Whole-body MR screening of muscles in the evaluation of neuromuscular diseases.

Authors:  O Ozsarlak; P M Parizel; A M De Schepper; P De Jonghe; J J Martin
Journal:  Eur Radiol       Date:  2004-03-09       Impact factor: 5.315

2.  Follistatin Gene Therapy for Sporadic Inclusion Body Myositis Improves Functional Outcomes.

Authors:  Jerry R Mendell; Zarife Sahenk; Samiah Al-Zaidy; Louise R Rodino-Klapac; Linda P Lowes; Lindsay N Alfano; Katherine Berry; Natalie Miller; Mehmet Yalvac; Igor Dvorchik; Melissa Moore-Clingenpeel; Kevin M Flanigan; Kathleen Church; Kim Shontz; Choumpree Curry; Sarah Lewis; Markus McColly; Mark J Hogan; Brian K Kaspar
Journal:  Mol Ther       Date:  2017-03-06       Impact factor: 11.454

3.  A phase 1/2a follistatin gene therapy trial for becker muscular dystrophy.

Authors:  Jerry R Mendell; Zarife Sahenk; Vinod Malik; Ana M Gomez; Kevin M Flanigan; Linda P Lowes; Lindsay N Alfano; Katherine Berry; Eric Meadows; Sarah Lewis; Lyndsey Braun; Kim Shontz; Maria Rouhana; Kelly Reed Clark; Xiomara Q Rosales; Samiah Al-Zaidy; Alessandra Govoni; Louise R Rodino-Klapac; Mark J Hogan; Brian K Kaspar
Journal:  Mol Ther       Date:  2014-10-17       Impact factor: 11.454

4.  Magnetic resonance imaging of children with Duchenne muscular dystrophy.

Authors:  A Schreiber; W L Smith; V Ionasescu; H Zellweger; E A Franken; V Dunn; J Ehrhardt
Journal:  Pediatr Radiol       Date:  1987

5.  Distinct muscle imaging patterns in myofibrillar myopathies.

Authors:  D Fischer; R A Kley; K Strach; C Meyer; T Sommer; K Eger; A Rolfs; W Meyer; A Pou; J Pradas; C M Heyer; A Grossmann; A Huebner; W Kress; J Reimann; R Schröder; B Eymard; M Fardeau; B Udd; L Goldfarb; M Vorgerd; M Olivé
Journal:  Neurology       Date:  2008-09-02       Impact factor: 9.910

6.  CT in neuromuscular disorders: a comparison of CT and histology.

Authors:  A M vd Vliet; H O Thijssen; E Joosten; J L Merx
Journal:  Neuroradiology       Date:  1988       Impact factor: 2.804

7.  CT and the diagnosis of myopathies. Preliminary findings in 42 cases.

Authors:  M Calò; G Crisi; C Martinelli; A Colombo; R Schoenhuber; M Gibertoni
Journal:  Neuroradiology       Date:  1986       Impact factor: 2.804

8.  Spinal muscular atrophy: MR evaluation.

Authors:  G C Liu; Y J Jong; C H Chiang; C W Yang
Journal:  Pediatr Radiol       Date:  1992

9.  Muscle CT, biopsy and EMG in diagnosis of neuromuscular diseases.

Authors:  M Gibertoni; A Colombo; R Schoenhuber; G Galassi; M Calò; G Crisi; C Martinelli
Journal:  Ital J Neurol Sci       Date:  1987-02

10.  Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study.

Authors:  Maria Kinali; Virginia Arechavala-Gomeza; Lucy Feng; Sebahattin Cirak; David Hunt; Carl Adkin; Michela Guglieri; Emma Ashton; Stephen Abbs; Petros Nihoyannopoulos; Maria Elena Garralda; Mary Rutherford; Caroline McCulley; Linda Popplewell; Ian R Graham; George Dickson; Matthew J A Wood; Dominic J Wells; Steve D Wilton; Ryszard Kole; Volker Straub; Kate Bushby; Caroline Sewry; Jennifer E Morgan; Francesco Muntoni
Journal:  Lancet Neurol       Date:  2009-08-25       Impact factor: 44.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.